FTC Seeks Public Comment on Healthcare Technology's Application to Sell SDI Health's Audit Businesses

The Federal Trade Commission seeks public comment on an application by Healthcare Technology Holdings, Inc., which is requesting approval to sell two audit businesses of SDI Health LLC to inVentiv Health, Inc. A divestiture is required by the final FTC settlement order allowing Healthcare Technology's subsidiary IMS Health Inc. to acquire SDI Health.

According to the application, the sale of SDI Health's audit businesses would satisfy the terms of the FTC's final order, which settled FTC charges that the deal would have been anticompetitive and in violation of the FTC and Clayton Acts. The audit businesses include SDI's promotional audit business and medical audit business.

The Commission will decide whether to approve the sale after the expiration of the public comment period. Public comments on the application may be submitted until February 27, 2012. Written comments should be sent to: FTC Office of the Secretary, 600 Pennsylvania Ave., N.W., Washington, DC 20580. Comments also can be filed electronically. Copies of the application also can be found on the FTC's website and as a link to this press release. (FTC File No. 111-0097, Docket No. C-4340; the staff contact is Roberta S. Baruch, Bureau of Competition, 202-326-2861; see press release dated October 28, 2011.)

The FTC's Bureau of Competition works with the Bureau of Economics to investigate alleged anticompetitive business practices and, when appropriate, recommends that the Commission take law enforcement action. To inform the Bureau about particular business practices, call 202-326-3300, send an e-mail to antitrust@ftc.gov, or write to the Office of Policy and Coordination, Bureau of Competition, Federal Trade Commission, 601 New Jersey Ave., Room 7117, Washington, DC 20580. To learn more about the Bureau of Competition, read Competition Counts. Like the FTC on Facebook and follow us on Twitter.